Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Equifax (EFX) Other Accumulated Expenses (2016 - 2025)

Equifax's Other Accumulated Expenses history spans 17 years, with the latest figure at $427.4 million for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses rose 6.0% year-over-year to $427.4 million; the TTM value through Dec 2025 reached $427.4 million, up 6.0%, while the annual FY2025 figure was $427.4 million, 6.0% up from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $427.4 million at Equifax, up from $413.4 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $649.7 million in Q3 2021 and bottomed at $265.2 million in Q2 2023.
  • The 5-year median for Other Accumulated Expenses is $370.0 million (2024), against an average of $402.4 million.
  • The largest annual shift saw Other Accumulated Expenses crashed 54.64% in 2022 before it grew 23.6% in 2024.
  • A 5-year view of Other Accumulated Expenses shows it stood at $638.2 million in 2021, then plummeted by 53.53% to $296.6 million in 2022, then grew by 12.85% to $334.7 million in 2023, then rose by 20.47% to $403.2 million in 2024, then rose by 6.0% to $427.4 million in 2025.
  • Per Business Quant, the three most recent readings for EFX's Other Accumulated Expenses are $427.4 million (Q4 2025), $413.4 million (Q3 2025), and $384.7 million (Q2 2025).